At a glance
ClinicalIndex Comparison RecordN/ACompleted· 44 enrolled
Drug / intervention
FullCeram implantdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Open Label Single Arm Study to Evaluate the Performance of Straumann Monotype FullCeram (Zirconium Dioxide) Implants in Single Tooth Gaps in the Maxilla and Mandible
In Brief
A clinical study evaluating FullCeram implant for Tooth Loss. Completed, enrolled 44 participants across 3 sites.
Detailed Summary
* Straumann Monotype FullCeram implants serve as a suitable alternative for implant therapy especially in the aesthetic zone * The survival rate of Straumann Ceramic implants should be at least 85% (max 6 implant losses out of 40 patients) after the first year
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTooth Loss
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2011
Primary CompletionSep 2013
First PostedJun 2014
Study CompletionNov 2023
TodayJul 2026
First PostedJun 13, 2014
Enrollment StartOct 1, 2011
Primary CompletionSep 1, 2013
Study CompletionNov 21, 2023
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 12.1 years ago
Interventions
FullCeram implantdevice
FullCeram implantation